OOIR: Observatory of International Research

Papers

(The TQCC of International Clinical Psychopharmacology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Immunomodulatory options for neurodevelopmental spectrum conditions: are we there yet?	42
The role of personality traits in following quarantine orders during the COVID-19 pandemic	35
Beyond antipsychotics: the role of medication and nonmedication factors in female sexual dysfunctions in schizophrenia	20
Does the comorbidity of borderline personality disorder affect the response to treatment in bipolar patients?	19
Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder	18
Catatonia as a debut of systemic lupus erythematosus: a case report on a diagnostic challenge	17
Age matters when improving symptoms of anxiety, depression, and sleepiness in patients with obstructive sleep apnea treated with continuous positive airway pressure	16
Sleep disturbance in schizophrenia spectrum disorders: more than just a symptom?	15
Antidepressant psychopharmacology: is inflammation a future target?	14
Risperidone combination therapy with adalimumab for treatment of chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial	14
Clinical specificity profile for novel rapid acting antidepressant drugs	13
Open issues in bipolar and antipsychotic treatments	12
Managing depression in the elderly: real-world clinical considerations and perspectives	12
Differential effectiveness between Ketamine and Esketamine: the predictive role of dissociative features. A treatment-resistant depression case	12
Case series on aripiprazole and dopamine supersensitivity psychosis	11
Dropped-Head syndrome: a possible new variant of clozapine-induced inflammation during titration	11
Validation of the Spanish version of the multifaceted empathy test: comparison between cannabis use effects and controls in social cognition	11
Debated issues in major psychoses	11
Remission of treatment-resistant obsessive-compulsive disorder with 600 milligrams of fluvoxamine daily: a case report	10
Differences in emotion recognition between nonimmersive versus immersive virtual reality: preliminary findings in schizophrenia and bipolar disorder	10
Prevalence and correlates of prescription drug abuse and misuse among adult prisoners: a systematic review	10
Persistence of suicidal ideation within acute phase treatment of major depressive disorder: analysis of clinical predictors	10
Towards a replicable protocol to identify patients with psychiatric disorders at higher risk of developing dementia	10
The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response?	10
The Gordian knot of the immune-redox systems’ interactions in psychosis	10

Prospective, comparative, pilot study of maintenance treatment in comorbid bipolar disorders with post-traumatic stress disorder	10
Selective serotonin reuptake inhibitors and quality of life: a meta-analysis of randomized placebo-controlled trials	10
Suicide in prison in the North of Italy (1993–2022): a case-control study examining differences between suicides inside and outside prison	10
Modulating factors in mood disorders treatment	9
Differentiating aspects of oral and long-acting injectable antipsychotic drugs for tailoring the therapy of schizophrenia in clinical practice: a narrative review	9
Elevated liver transaminases among patients with psychiatric disorders	9
Suicide behind bars: time to tackle barriers to mental healthcare access in prisons	9
Immediate-release vs. prolonged-release lithium formulations in bipolar disorder: a 2-year comparative study	8
Repeated subcutaneous racemic ketamine in treatment-resistant depression: case series	8
Systematic literature review and network meta-analysis of lurasidone, brexpiprazole and cariprazine for schizophrenia	8
Navigating the pharmacologic complexities of QTc prolongation: assessing the cumulative burden in individuals with serious mental illness	8
Vitamin E in the treatment of tardive dyskinesia: a meta-analysis	8
Allergic reaction induced by subcutaneous administration of ketamine: a case report	8
Innovation in psychopharmacology	8
The impact of mild behavioral impairment on the prognosis of geriatric depression: preliminary results	8
Obsessive-compulsive symptoms in major depressive disorder correlate with clinical severity and mixed features	8
Advances in the treatment of depression	7
Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled 6-week studies	7
Manic episode in a patient with pancreatic adenocarcinoma: a case report	7
Case report and systematic review of cerebellar vermis alterations in psychosis	7
Treatment adherence in forensic patients with schizophrenia spectrum disorders discharged on long-acting injectable antipsychotics: a comparative 3-year mirror-image study	7
Cariprazine: an augmentation strategy for treatment-resistant schizophrenia with pro-cognitive and anti-hostility effects	7
Increased risk of death compared to other antipsychotics in elderly clozapine users in Poland	6
Patterns of antipsychotic prescription and accelerometer-based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, prospective study	6
Mental health in patients affected by atopic dermatitis: which effects of treatment with dupilumab?	6
Persian translation and validation of community attitudes toward the mentally ill scale: a tool for assessing social stigma about mental illness	6
Interplay of environmental and clinical factors in psychiatric disorders	6
Capillary blood sampling for the determination of clozapine concentrations: analytical validation and patient experience	6
Differentiating the third generation of antipsychotics: a focus on lumateperone’s similarities and differences	6
Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial	6
Long-term remission following esketamine nasal spray sessions in a patient with severe and highly treatment-resistant depression: a single-case report	6
The challenge of managing difficult to treat psychiatric conditions	6
The relationship between mobile phone addiction and depression, anxiety, and sleep quality in medical students	6